ABC | Volume 110, Nº1, January 2018

Original Article Fischer et al Gene polymorphisms and coronary disease extension Arq Bras Cardiol. 2018; 110(1):16-23 12. Izar MC, Helfenstein T, Ihara SS, Relvas WG, Santos AO, Fischer SC, et al; GOLD Investigators. Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes: the genetics, outcomes, and lipids in type 2 diabetes (GOLD) study. Atherosclerosis. 2009;204(1):165- 70. doi: 10.1016/j.atherosclerosis.2008.08.006. 13. Kaur R, Matharoo K, Sharma R, Bhanwer AJ. C-reactive protein + 1059 G>C polymorphism in type 2 diabetes and coronary artery disease patients. Meta Gene. 2013;1:82-92. doi: 10.1016/j.mgene.2013.10.012. 14. Song Z, Cao H, Qin L, Jiang Y. A case-control study between gene polymorphisms of polyunsaturated fatty acid metabolic rate-limiting enzymes and acute coronary syndrome inChineseHan population. Biomed Res Int. 2013;2013:928178. doi: 10.1155/2013/928178. 15. Palmer BR, Slow S, Ellis KL, Pilbrow AP, Skelton L, Frampton CM, et al. Genetic polymorphism rs6922269 in the MTHFD1L gene is associated with survival and baseline active vitamin B12 levels in post-acute coronary syndromes patients. PLoS One. 2014;9(3):e89029. doi: 10.1371/journal. pone.0089029. 16. Ellis KL, Zhou Y, Beshansky JR, Ainehsazan E, Selker HP, Cupples LA, et al. Genetic modifiers of response to glucose-insulin-potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial. Pharmacogenomics J. 2015;15(6):488-95. doi: 10.1038/tpj.2015.10. 17. Ference BA. Mendelian randomization studies: using naturally randomized genetic data to fill evidence gaps. Curr Opin Lipidol. 2015;26(6):566-71. doi: 10.1097/MOL.0000000000000247. 18. Holmes MV, Asselbergs FW, Palmer TM, Drenos F, LanktreeMB, Nelson CP, et al. Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J. 2015;36(9):539-50. doi: 10.1093/eurheartj/eht571. 19. Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovasculardisease:Newinsightsfromepidemiology,genetics,andbiology. Circ Res. 2016;118(4):547-63. doi: 10.1161/CIRCRESAHA.115.306249. 20. Jia EZ, Chen ZH, An FH, Li LH, Li-Li, Guo CY, et al. Relationship of renin-angiotensin-aldosterone system polymorphisms and phenotypes to mortality in Chinese coronary atherosclerosis patients. Sci Rep. 2014;4:4600. doi: 10.1038/srep04600. 21. Osadnik T, Strzelczyk JK, LekstonA, Reguła R, Bujak K, FronczekM, et al. The association of functional polymorphisms in genes encoding growth factors for endothelial cells and smooth muscle cells with the severity of coronary artery disease. BMC Cardiovasc Disord. 2016;16(1):218. doi: 10.1186/ s12872-016-0402-4. 22. YangM,ZhuM,TangL,ZhuH,LuY,XuB,etal.PolymorphismsofTGF β -1and TGFBR2 in relation to coronary artery disease in a Chinese population. Clin Biochem. 2016;49(12):873-8. doi: 10.1016/j.clinbiochem.2016.05.022. 23. Anderson JL, Horne BD, Camp NJ, Muhlestein JB, Hopkins PN, Cannon- Albright LA, et al. Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease. Am Heart J. 2010;160(2):250-256.e3. doi: 10.1016/j.ahj.2010.05.031. 24. Brautbar A, Pompeii LA, Dehghan A, Ngwa JS, Nambi V, Virani SS, et al. A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis. 2012;223(2):421-6. doi: 10.1016/j. atherosclerosis.2012.05.035. 25. Shah S, Casas JP, Gaunt TR, Cooper J, Drenos F, Zabaneh D, et al. Influence of common genetic variation on blood lipid levels, cardiovascular risk, and coronary events in two British prospective cohort studies. Eur Heart J. 2013;34(13):972-81. doi: 10.1093/eurheartj/ehs243. 26. Faludi AA, Izar MC, Saraiva JF, Chacra AP, Bianco HT, Afiune Neto A, et al. Atualizaço da Diretriz Brasileira de dislipidemias e prevenço da aterosclerose – 2017. Arq Bras Cardiol 2017; 109(2Supl.1):1-76. doi: 10.5935/abc.20170121. 27. Sposito AC, Caramelli B, Fonseca FA, Bertolami MC, Afiune Neto A, Souza AD, et al; Sociedade Brasileira de Cardiologia. [IV Brazilian Guideline for DyslipidemiaandAtherosclerosisprevention:DepartmentofAtherosclerosis of Brazilian Society of Cardiology]. Arq Bras Cardiol. 2007;88 Suppl 1:2-19. doi: http://dx.doi.org/10.1590/S0066-782X2007000700002. 28. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute.; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-52. doi: 10.1161/01.HYP.0000107251.49515.c2 . 29. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituricacidreaction.AnalBiochem.1979;95(2):351-8.PMID:36810. 30. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow- mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J AmColl Cardiol. 2002;39(2):257-65. PMID: 11788217. Erratum in: J Am Coll Cardiol. 2002;39(6):1082. 31. Gensini GG. Amoremeaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51(3):606. PMID: 6823874. 32. Rebhi L, Kchok K, Omezzine A, Kacem S, Rejeb J, Ben HadjMbarek I, et al. Six lipoprotein lipase gene polymorphisms, lipid profile and coronary stenosis in a Tunisian population. Mol Biol Rep. 2012;39(11):9893-901. doi: 10.1007/s11033-012-1856-9 . 33. Corsetti JP, Gansevoort RT, Navis G, Sparks CE, Dullaart RP. LPL polymorphism (D9N) predicts cardiovascular disease risk directly and through interaction with CETP polymorphism (TaqIB) in women with high HDL cholesterol and CRP. Atherosclerosis. 2011;214(2):373-6. doi: 10.1016/j.atherosclerosis.2010.11.029. 34. Ariza MJ, Sánchez-Chaparro MA, Barón FJ, Hornos AM, Calvo-Bonacho E, RiojaJ,etal.AdditiveeffectsofLPL,APOA5andAPOEvariantcombinationson triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub- study.BMCMedGenet.2010Apr29;11:66.doi:10.1186/1471-2350-11-66. 35. RigoliL,RaimondoG,DiBenedettoA,RomanoG,PorcelliniA,CampoS,etal. ApolipoproteinAI-CIII-AIVgeneticpolymorphismsandcoronaryheartdisease intype2diabetesmellitus.ActaDiabetol.1995;32(4):251-6.PMID:8750764. 36. SahinS,CeyhanK,Benli I,OzyurtH,NaseriE,TumukluMM,etal.Traditional risk factors and angiotensin-converting enzyme insertion/deletion gene polymorphism in coronary artery disease. GenetMol Res. 2015;14(1):2063- 8. doi: 10.4238/2015.March.20.16. 37. TangWH, Hartiala J, Fan Y,Wu Y, Stewart AF, Erdmann J, et al; CARDIoGRAM Consortium. Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk. Arterioscler Thromb Vasc Biol. 2012;32(11):2803-12. doi: 10.1161/ATVBAHA.112.253930. 38. Hou X, Chen X, Shi J. Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: a meta-analysis. Gene. 2015;565(1):39-44. doi: 10.1016/j.gene.2015.03.062. 39. HelfensteinT,FonsecaFA,RelvasWG,SantosAO,DabelaML,MatheusSC,et al.Prevalenceofmyocardialinfarctionisrelatedtohyperhomocysteinemiabut not influenced by C677Tmethylenetetrahydrofolate reductase andA2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects. Clin ChimActa. 2005;355(1-2):165-72. doi: 10.1016/j.cccn.2004.12.002 . 40. Mahmoodi K, Nasehi L, Karami E, Soltanpour MS. Association of nitric oxide levels and endothelial nitric oxide synthase G894T polymorphism with coronary artery disease in the Iranian population. Vasc Specialist Int. 2016;32(3):105-12. doi: 10.5758/vsi.2016.32.3.105. 41. LiuD,JiangZ,DaiL,ZhangX,YanC,HanY.Associationbetweenthe-786T>C 1polymorphism in the promoter region of endothelial nitric oxide synthase (eNOS) and risk of coronary artery disease: a systematic review and meta- analysis. Gene. 2014;545(1):175-83. doi: 10.1016/j.gene.2013.09.099. 22